Study reveals immune cell levels as prognostic marker in early-stage triple-negative

[News]

A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy.

More... (https://www.news-medical.net/news/20240402/Study-reveals-immune-cell-levels-as-prognostic-marker-in-early-stage-triple-negative-breast-cancer.aspx)